Connect with us

Hi, what are you looking for?

press release

Idorsia congratulates its Chief Scientific Officer Martine Clozel – Press Release

  • Martine Clozel was awarded the Prix Suisse for her services to research, science and medicine and was awarded the Prix Suisse by the President of the National Council, Irène Kälin
  • The Prix Suisse is an annual award given by the non-profit organization Initiative Schweiz to individuals who have made outstanding contributions to Switzerland

Allschwil, Switzerland – November 13, 2022
Idorsia Ltd IDIA announced today that Chief Scientific Officer Martine Clozel was presented with the annual Prix Suisse Award by the organization Initiative Schweiz at an awards ceremony in the Kursaal Bern on Saturday, November 12. The Prix Suisse is a national award and represents the highest award for outstanding achievements in Switzerland and was presented to Martine by Irène Kälin, President of the Swiss National Council.

In her introduction, Irène Kalin commented:
“Martine Clozel deserves an award for every single facet of her diverse work. The sum of all her work is greater than what she has achieved as a doctor, entrepreneur and researcher in their respective fields. An incredibly impressive woman.”

Martine Clozel is Founder and Chief Scientific Officer at Idorsia. She previously co-founded Actelion with Jean-Paul Clozel, Walter Fischli and Thomas Widmann. Martine has published more than 150 peer-reviewed articles, authored more than 40 patent applications and several books in the fields of endothelin and…

Source Story here

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...